Close Menu
    Facebook X (Twitter) Instagram
    • Home
    • About Us
    • Digital Subscription
    • Advertisement
    • Contact Us
    Facebook X (Twitter) Instagram
    The Tennessee TribuneThe Tennessee Tribune
    Advertise With Us
    • Home
      • COVID-19 Resource Center
        • Dr. Henry Louis Gates’ PSA Radio
      • Featured
    • News
      • State
      • Local
      • National/International News
      • Global
      • Business
        • Commentary
        • Finance
        • Local Business
      • Investigative Stories
        • Affordable Housing
        • DCS Investigation
        • Gentrification
    • Editorial
      • National Politics
      • Local News
      • Local Editorial
      • Political Editorial
      • Editorial Cartoons
      • Cycle of Shame
    • Community
      • History
      • Tennessee
        • Chattanooga
        • Clarksville
        • Knoxville
        • Memphis
      • Public Notices
      • Women
        • Let’s Talk with Ms. June
    • Education
      • College
        • American Baptist College
        • Belmont University
        • Fisk
        • HBCU
        • Meharry
        • MTSU
        • University of Tennessee
        • TSU
        • Vanderbilt
      • Elementary
      • High School
    • Lifestyle
      • Art
      • Auto
      • Tribune Travel
      • Entertainment
        • 5 Questions With
        • Books
        • Events
        • Film Review
        • Local Entertainment
      • Family
      • Food
        • Drinks
      • Health & Wellness
      • Home & Garden
      • Featured Books
    • Religion
      • National Religion
      • Local Religion
      • Obituaries
        • National Obituaries
        • Local Obituaries
      • Faith Commentary
    • Sports
      • MLB
        • Sounds
      • NBA
      • NCAA
      • NFL
        • Predators
        • Titans
      • NHL
      • Other Sports
      • Golf
      • Professional Sports
      • Sports Commentary
      • Metro Sports
    • Media
      • Video
      • Photo Galleries
      • Take 10
      • Trending With The Tribune
    • Classified
    • Obituaries
      • Local Obituaries
      • National Obituaries
    The Tennessee TribuneThe Tennessee Tribune
    National/International News

    New Startup Helps Pfizer Create More Effective, Targeted Drugs For Patients

    zenger.newsBy zenger.newsMarch 30, 2021No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Pfizer, the pharmaceutical giant, is now a household name, thanks to developing one of the leading vaccines against COVID-19.

    Now, an Israeli startup will help the New York-based firm produce the next generation of drugs more efficiently and effectively — whether that’s a booster shot against the novel coronavirus or an entirely different class of drugs.

    CytoReason has a machine-learning platform that essentially serves as a “GPS for the immune system.” For Pfizer, that means aggregating data from sources including in-house data, clinical studies and the large body of published research on the immune system.

    The Pfizer logo is viewed on their world headquarters in Manhattan on May 5, 2014 in New York City. (Photo by Spencer Platt/Getty Images)

    Just as a GPS traffic app helps find the fastest route home, Pfizer scientists can use CytoReason’s machine-learning model to uncover insights into the biology of autoimmune diseases, suggest new drug targets and identify patients who may benefit the most from a certain medicine.

    CytoReason’s technology can uncover critical information on immune functioning down to the molecular level. With the estimated cost of developing a new FDA-approved medicine at $2.6 billion, its focus has enormous real-world implications.

    “We believe that CytoReason’s platform has the potential to offer valuable insights that may be applied to our research into the human immune system,” said Michael Vincent, Chief Scientific Officer, Inflammation & Immunology, Pfizer. “Leveraging technologies such as this can help us understand disease, prioritize targets and support our mission of bringing innovative new therapies to patients who need them.”

    CytoReason has relationships with three of the world’s eight largest pharmaceutical companies and has collaborated with British multinational GlaxoSmithKline and the Parker Institute for Cancer Immunotherapy. CytoReason has a partnership with Summit Pharmaceuticals of Japan.

    CytoReason has “one of the world’s largest libraries of human molecular data and a platform to make that data accessible and useful,” the company says. “CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients, at the right time.”

    Founded in 2016 by researchers and scientists from the Technion – Israel Institute of Technology, the company’s technology has yielded five pending patents, 10 commercial and scientific collaborations, and 17 peer-reviewed publications.

    (Edited by Fern Siegel and David Martosko)

    Israeli AI to help Pfizer develop its next drugs appeared first on ISRAEL21c.



    The post New Startup Helps Pfizer Create More Effective, Targeted Drugs For Patients appeared first on Zenger News.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    zenger.news
    • Website

    Related Posts

    Community Invited to Join Tours of the Obama Presidential Center

    August 24, 2025

    Black Church and Black Press Unite to Empower Black America

    July 26, 2025

    Malcolm-Jamal Warner, ‘Cosby Show’ Actor, Dies at 54 in Costa Rica Drowning

    July 21, 2025

    Anti-Donald Trump Protests Planned Nationwide for July 17: What to Know

    July 10, 2025

    Emmett Till National Monument May Be Removed Under Trump Admin

    June 28, 2025

    Black Americans Face Unequal Burden as U.S. Inches Closer to War

    June 22, 2025

    Comments are closed.

    Advertisement
    Business

    Sprouts Farmers Market Hosts Hiring Event Ahead of Mt. Juliet Opening

    August 28, 2025

    NBCC MINORITY BUSINESS OF THE WEEK: Flying Dress

    August 20, 2025

    Toon appointed new role at MMCV

    August 16, 2025
    1 2 3 … 386 Next
    Education
    Education

    MNPS hits milestone

    By adminSeptember 2, 2025

    NASHVILLE, TN — MNPS is celebrating a historic milestone: for the fourth year in a…

    Belmont’s Massey College of Business Awards $10,000 Scholarships to All 2025 NELAS Winners

    September 1, 2025

    TSU President Tucker Appoints Three New Leaders to Advance Transformational Change Agenda

    August 28, 2025

    Meharry Medical College Serves More Than 450 Dental Patients at Biannual Oral Health Day

    August 28, 2025
    The Tennessee Tribune
    Facebook X (Twitter) Instagram
    • About Us
    • Digital Subscription
    • Store
    • Advertise With Us
    • Contact
    © 2025 The Tennessee Tribune - Site Designed by No Regret Media.

    Type above and press Enter to search. Press Esc to cancel.

    Our Spring Sale Has Started

    You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/